Kuo‐Long Yu

1.2k total citations
29 papers, 763 citations indexed

About

Kuo‐Long Yu is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Kuo‐Long Yu has authored 29 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Epidemiology and 9 papers in Organic Chemistry. Recurrent topics in Kuo‐Long Yu's work include Respiratory viral infections research (8 papers), Retinoids in leukemia and cellular processes (6 papers) and Plant Virus Research Studies (6 papers). Kuo‐Long Yu is often cited by papers focused on Respiratory viral infections research (8 papers), Retinoids in leukemia and cellular processes (6 papers) and Plant Virus Research Studies (6 papers). Kuo‐Long Yu collaborates with scholars based in United States, Germany and Italy. Kuo‐Long Yu's co-authors include Bert Fraser‐Reid, Nicholas A. Meanwell, Christopher Cianci, Mark Krystal, Peter R. Reczek, John E. Starrett, Keith D. Combrink, Laura Hammer, Zhufang Li and Jacek Ostrowski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Kuo‐Long Yu

28 papers receiving 720 citations

Peers

Countries citing papers authored by Kuo‐Long Yu

Since Specialization

Citations

This map shows the geographic impact of Kuo‐Long Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuo‐Long Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuo‐Long Yu more than expected).

Fields of papers citing papers by Kuo‐Long Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuo‐Long Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuo‐Long Yu. The network helps show where Kuo‐Long Yu may publish in the future.

Co-authorship network of co-authors of Kuo‐Long Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Kuo‐Long Yu. A scholar is included among the top collaborators of Kuo‐Long Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuo‐Long Yu. Kuo‐Long Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 4525: Discovery of a highly potent and selective PARP1 inhibitor with superior PK and safety profiles 2024 ·Cancer Research ·Wei Yi, Wenming Li, Zehui Li, Manhua Li, (unknown), Zhiming Wen, Tinggui Yin, Kuo‐Long Yu, Genshi Zhao, Hongbin Yuan	1
2	Novel 3-Aryl Indoles as Progesterone Receptor Antagonists for Uterine Fibroids 2010 ·ACS Medicinal Chemistry Letters ·Timothy I. Richardson, (unknown), Kuo‐Long Yu, Ying K. Yee, Thomas J. Bleisch, José Enrique López, Scott A. Jones, (unknown), (unknown), Charles W. Lugar, Terry L. Moore, Pamela K. Shetler, Richard W. Zink, John Osborne, Chahrzad Montrose‐Rafizadeh, Nita Patel, Andrew G. Geiser, Rachelle J. Sells Galvin, Jeffrey A. Dodge	46
3	Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo 2009 ·Bioorganic & Medicinal Chemistry Letters ·Ny Sin, Brian L. Venables, Keith D. Combrink, H. Belgin Gülgeze, Kuo‐Long Yu, Rita L. Civiello, Jan Willem Thuring, (unknown), Zheng Yang, Lisa Zadjura, Anthony M. Marino, Kathleen F. Kadow, Christopher Cianci, (unknown), Eugene V. Genovesi, Ivette Medina, Lucinda Lamb, Mark Krystal, Nicholas A. Meanwell	36
4	Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Christopher Cianci, Kuo‐Long Yu, Keith D. Combrink, Jan Willem Thuring, Yi Zhang, Rita L. Civiello, Kathleen F. Kadow, (unknown), Zhufang Li, David R. Langley, Mark Krystal, Nicholas A. Meanwell	22
5	Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety 2007 ·Bioorganic & Medicinal Chemistry Letters ·Keith D. Combrink, H. Belgin Gülgeze, Jan Willem Thuring, Kuo‐Long Yu, Rita L. Civiello, Yi Zhang, Bradley C. Pearce, Zhiwei Yin, David R. Langley, Kathleen F. Kadow, Christopher Cianci, Zhufang Li, (unknown), Eugene V. Genovesi, Ivette Medina, Lucinda Lamb, Zheng Yang, Lisa Zadjura, Mark Krystal, Nicholas A. Meanwell	31
6	Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo 2005 ·Bioorganic & Medicinal Chemistry Letters ·Kuo‐Long Yu, (unknown), Rita L. Civiello, Ashok K. Trehan, Bradley C. Pearce, Zhiwei Yin, Keith D. Combrink, H. Belgin Gülgeze, Yi Zhang, Kathleen F. Kadow, Christopher Cianci, (unknown), Eugene V. Genovesi, Ivette Medina, Lucinda Lamb, Philip R. Wyde, Mark Krystal, Nicholas A. Meanwell	31
7	Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives 2004 ·Bioorganic & Medicinal Chemistry Letters ·Kuo‐Long Yu, Yi Zhang, Rita L. Civiello, Ashok K. Trehan, Bradley C. Pearce, Zhiwei Yin, Keith D. Combrink, H. Belgin Gülgeze, (unknown), Kathleen F. Kadow, Christopher Cianci, Mark Krystal, Nicholas A. Meanwell	24
8	Targeting a binding pocket within the trimer-of-hairpins: Small-molecule inhibition of viral fusion 2004 ·Proceedings of the National Academy of Sciences ·Christopher Cianci, David R. Langley, Douglas D. Dischino, Yaxiong Sun, Kuo‐Long Yu, Anne Stanley, (unknown), Zhufang Li, R. A. Dalterio, Richard J. Colonno, Nicholas A. Meanwell, Mark Krystal	80
9	A Chemical Switch Regulates Fibrate Specificity for Peroxisome Proliferator-activated Receptor α (PPARα) VersusLiver X Receptor 2003 ·Journal of Biological Chemistry ·(unknown), Kelli Bramlett, Chahrzad Montrose, Patricia Foxworthy, Patrick I. Eacho, Denis McCann, Guoqing Cao, (unknown), (unknown), Kuo‐Long Yu, Timothy A. Grese, William W. Chin, Thomas P. Burris, Laura F. Michael	54
10	Development of a photoaffinity label for respiratory syncytial virus inhibitors 2003 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Douglas D. Dischino, Christopher Cianci, Rita L. Civiello, Mark Krystal, Nicholas A. Meanwell, Hiromi Morimoto, Philip G. Williams, Kuo‐Long Yu	5
11	Salicylamide inhibitors of influenza virus fusion 2000 ·Bioorganic & Medicinal Chemistry Letters ·Keith D. Combrink, H. Belgin Gülgeze, Kuo‐Long Yu, Bradley C. Pearce, Ashok K. Trehan, Jianmei Wei, Milind Deshpande, Mark Krystal, Albert Torri, Guangxiang Luo, Christopher Cianci, (unknown), Laurence Tiley, Nicholas A. Meanwell	17
12	Solid-phase synthesis of benzisothiazolones as serine protease inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·Kuo‐Long Yu, Rita L. Civiello, Daniel G. Roberts, Steven M. Seiler, Nicholas A. Meanwell	6
13	Stereoselective reduction via lithium borotritide: synthesis of3H-labeled 2-hydroxy-N-[(5-hydroxy-[5-3H]-1,3,3-trimethylcyclohexyl)methyl]-5-methylbenzamide 1999 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Douglas D. Dischino, Nicholas A. Meanwell, Hiromi Morimoto, Bradley C. Pearce, (unknown), Albert Torri, Philip G. Williams, Kuo‐Long Yu	1
14	ChemInform Abstract: Novel Quinolizidine Salicylamide Influenza Fusion Inhibitors. 1999 ·ChemInform ·Kuo‐Long Yu, (unknown)	2
15	Serine 232 and Methionine 272 Define the Ligand Binding Pocket in Retinoic Acid Receptor Subtypes 1998 ·Journal of Biological Chemistry ·Jacek Ostrowski, (unknown), Laura Hammer, Anne Marinier, John E. Starrett, Kuo‐Long Yu, Peter R. Reczek	35
16	Application of the Heck reaction in the synthesis of truncated naphthoic acid retinoids 1996 ·Bioorganic & Medicinal Chemistry Letters ·Kuo‐Long Yu, Simon Chen, Jacek Ostrowski, Kenneth M. Tramposch, Peter R. Reczek, Muzammil M. Mansuri, John E. Starrett	12
17	Retinoic Acid Receptor Gamma Mediates Topical Retinoid Efficacy and Irritation in Animal Models 1995 ·Journal of Investigative Dermatology ·Simon Chen, (unknown), Gary S. Whiting, (unknown), Laura Hammer, Stephen J. Currier, (unknown), (unknown), Kuo‐Long Yu, Roman Sterzycki, Choung U. Kim, John E. Starrett, Muzammil M. Mansuri, Peter R. Reczek	56
18	Role of Retinoic Acid Receptor Gamma in the Rhino Mouse and Rabbit Irritation Models of Retinoid Activity 1995 ·Skin Pharmacology and Physiology ·Peter R. Reczek, Jacek Ostrowski, Kuo‐Long Yu, Simon Chen, Laura Hammer, (unknown), John E. Starrett, (unknown), Gary S. Whiting, (unknown), Kenneth M. Tramposch, Muzammil M. Mansuri	16
19	Facial-selective carbohydrate-based aldol additions 1989 ·Journal of the Chemical Society Chemical Communications ·Kuo‐Long Yu, Bert Fraser‐Reid	6
20	A novel reagent for the synthesis of -inositol phosphates: ,-diisopropyl dibenzyl phosphoramidite 1988 ·Tetrahedron Letters ·Kuo‐Long Yu, Bert Fraser‐Reid	148

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact